Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene 
therapy

Sato, T.; Neschadim, A.; Konrad, M.; Fowler, D. H.; Lavie, A.; Medin, J. A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy

MPS-Authors

/persons/resource/persons15362

Konrad, M.
Research Group of Enzyme Biochemistry, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Sato, T., Neschadim, A., Konrad, M., Fowler, D. H., Lavie, A., & Medin, J. A. (2007). Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. Molecular Therapy, 15(5), 962-970. Retrieved from http://www.nature.com/mt/journal/v15/n5/full/6300122a.html.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-E295-9

Abstract

There is no abstract available